Sec. Cancer Molecular Targets and Therapeutics
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1294881
A Retraction of the Original Research Article
AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway
by Wang X, Dai Y, Zhao Y, Li M, Zhang J, Ci Y, Wang H and Li X (2021) Front. Oncol. 11:665105. doi: 10.3389/fonc.2021.665105
The journal retracts the May 12, 2021, article cited above.
Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, the editors no longer have confidence in the findings presented in the article.
This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers.
The authors agreed with this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: AnnexinA5 might suppress the phenotype of human gastric cancer cells via ERK pathway. Front. Oncol. 13:1294881. doi: 10.3389/fonc.2023.1294881
Received: 15 September 2023; Accepted: 19 September 2023;
Published: 28 September 2023.
Approved by:Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, email@example.com